Table 1.
Current drug discovery status of OXT and endophenotypes of depression.
| Study Center | Study aims |
|---|---|
| University of North Carolina | Social functioning / decrease paranoia and psychotic symptoms in schizophrenia |
| University of California / Stanley Medical Research Institute | Augmentation of antipsychotics in schizophrenia patients |
| Lawson Health Research Institute / Alzheimer’s Society London & Middlesex | Social cognition in frontotemporal dementia |
| Sheba Medical Center | Prevention of post-traumatic stress disorder |
| University of Maryland / NIMH | Social affliation, anxiety and cognition |
| Harvard School of Public Health / Brigham and Women’s Hospital | Amelioration of the neuroendocrine and cardiovascular effects of stress |
| University of California | Add-on for stable anxiety patients |
| NIDA / University of Maryland | Drug dependence |
| NIMH | Functioning of neurocognitive symptoms in mood disorders (together with AVP) |
| NIMH | Affectionate writing in response to acute stress |